NCT00289003View on ClinicalTrials.gov

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

July 31, 2006

Conditions
Oral Mucositis
Interventions
DRUG

Soluble beta-1,3/1,6-glucan

Trial Locations (3)

40217

Evangelisches Krankenhaus, Düsseldorf

53119

Medical Centre Bonn, Clinic for Radiotherapy and Radiological Oncology, Bonn

SW3 6JJ

Royal Marsden Hospital, Head and Neck Unit, London

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY